HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4.

Abstract
Pharmacological targeting of G protein-coupled receptors (GPCRs) is of great importance to human health, as dysfunctional GPCR-mediated signaling contributes to the progression of many diseases. The ligand/receptor pair CXC chemokine ligand 12 (CXCL12)/CXC chemokine receptor 4 (CXCR4) has raised significant clinical interest, for instance as a potential target for the treatment of cancer and inflammatory diseases. Small molecules as well as therapeutic antibodies that specifically target CXCR4 and inhibit the receptor's function are therefore considered to be valuable pharmacological tools. Here, a flow cytometry-based cellular assay that allows identification of compounds (e.g., small molecules) that abrogate CXCL12 binding to CXCR4, is described. Essentially, the assay relies on the competition for receptor binding between a fixed amount of fluorescently labeled CXCL12, the natural chemokine agonist for CXCR4, and unlabeled compounds. Hence, the undesirable use of radioactively labeled probes is avoided in this assay. In addition, living cells are used as the source of receptor (CXCR4) instead of cell membrane preparations. This allows easy adaptation of the assay to a plate format, which increases the throughput. This assay has been shown to be a valuable generic drug discovery assay to identify CXCR4-targeting compounds. The protocol can likely be adapted to other GPCRs, at least if fluorescently labeled ligands are available or can be generated. Prior knowledge concerning the intracellular signaling pathways that are induced upon activation of these GPCRs, is not required.
AuthorsGeert Schoofs, Anneleen Van Hout, Thomas D'huys, Dominique Schols, Tom Van Loy
JournalJournal of visualized experiments : JoVE (J Vis Exp) Issue 133 (03 10 2018) ISSN: 1940-087X [Electronic] United States
PMID29578516 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Video-Audio Media)
Chemical References
  • CXCL12 protein, human
  • CXCR4 protein, human
  • Chemokine CXCL12
  • Fluorescent Dyes
  • Ligands
  • Receptors, CXCR4
  • Small Molecule Libraries
Topics
  • Binding, Competitive
  • Chemokine CXCL12 (antagonists & inhibitors, metabolism)
  • Drug Evaluation, Preclinical (methods)
  • Flow Cytometry (methods)
  • Fluorescent Dyes
  • Humans
  • Jurkat Cells
  • Ligands
  • Protein Binding
  • Receptors, CXCR4 (antagonists & inhibitors, metabolism)
  • Small Molecule Libraries (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: